Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

Summary

The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pediatric Growth Hormone Deficiency (PGHD) in naive to treatment children and validate the LUM-201 predictive enrichment marker (LUM-201 PEM) strategy to select subjects likely to respond to therapy with daily oral LUM-201.

Timeline

Start

2026-05-20

Primary completion

2027-12

Completion

2028-01

Drugs

Indications